Subscribe rss-microbe
Home Current Topics
Current Topics
Promising in Trial, Malaria Vaccine Inches toward Deployment Print E-mail
Interim results from a large clinical trial show that RTS, S/AS01vaccine cut the incidence of malaria by half among children aged 5 to 17 months.
 
Moth Virus Changes Host Behavior to Suit Parasitic Demands Print E-mail
Viruses can manipulate the behavior of their insect hosts, according to Kelli Hoover at Pennsylvania State University (PSU) in University Park and her collaborators there and at the U.S. Department of Agriculture Forest Service (FS) facility in Delaware, Ohio.
 
A Peek at Antibiotic Development Strategies in University Settings Print E-mail

Audio interview--Eric Brown of McMaster University

Microbial genomics as a strategy for developing antimicrobial drugs "failed to deliver" in part because "we don't understand the biology," says Eric Brown of McMaster University in Hamilton, Ontario, Canada.

 
Advantages Seen for Wider Use of Needle-Free Vaccine Delivery Print E-mail
The prospects for needle-free delivery of vaccines look bright, and this approach offers advantages that go beyond pain-free inoculations, according to Bruce Weniger of Vaccine and formerly of the Centers for Disease Control and Prevention (CDC) in Atlanta, Ga.
 
Chemical Compound Selectively Kills Persister Bacterial Cells Print E-mail

 

Although neither antibiotics nor the compound "C10" when used alone can kill antibiotic-resistant persister bacterial cells, pairing C10 with antibiotics proves effective, according to Dae-Hyuk Kweon, of Sungkyunkwan University, South Korea, and his collaborators.
 
Broadly Antiviral Squalamine from Sharks Blocks Host Virus Receptors Print E-mail
Squalamine, a compound from sharks that is known for its anticancer activity, also has broad-spectrum antiviral activity, according to Michael Zasloff of Georgetown University Medical Center in Washington, D.C., and his collaborators.
 
Minitopics Print E-mail

Click the title to view all the mini-topics for this issue.